For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

Welcoming a newborn is something many couples dream of doing, but it can get complicated when conceiving becomes a roadblock.

Personalized Health Rx™ (PHRx), a new direct-to-consumer telehealth platform under the parent brand Persona 3.0 and sister company to Persona™ Nutrition, opened its digital doors today with a mission ...

Hy-Vee dietitian Julie Gallagher joins us to review GLP-1 receptor agonists (Ozempic, Wegovy and Rybelsus) and the importance of evidence-based nutrition guidance while taking them.

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...